Transforming revenue visibility
R&Q’s latest transaction, the creation of Gibson Re as a ‘sidecar’ for future legacy deals, should...
Read moreBenchmark Holdings - Strong Q3 for Nutrition and Genetics
Benchmark Holdings’ recent Q3 (March-June) results show strong revenue and profit growth in its...
Read moreH1 2021 interims: still on track
Destiny's interim H1 2021 financial results were an upbeat and extensive update on the clinical...
Read moreAUM growth ahead of forecasts and segment
On 31 August 2021, two months into financial Q4 and 11 months into FY21, AUM reached £38.0bn,...
Read more
FY21 interim results: a strong rebound
For the six months to 30 June 2021 Mpac Group reported a strong recovery in both orders, +69%YoY,...
Read more
Confident AGM And Trading Update
RUA Life Sciences’ AGM statement and trading update demonstrated good progress across its...
Read moreFull occupancy and strong portfolio outlook
The interims from RAV confirm momentum building behind portfolio values as lower vacancy rates...
Read moreAnother year of good growth delivered
UPGS’s pre-close FY2021 trading statement confirmed a strong end to the financial year with most...
Read moreContinued strong execution & positive outlook
Given the tightening UK jobs market with vacancies back to pre-covid levels, it’s no wonder...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
